These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34503219)

  • 41. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
    de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
    Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
    Cha YJ; Ahn SG; Bae SJ; Yoon CI; Seo J; Jung WH; Son EJ; Jeong J
    Breast Cancer Res Treat; 2018 Sep; 171(2):295-302. PubMed ID: 29869774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer.
    Garcia V; Elfer K; Peeters DJE; Ehinger A; Werness B; Ly A; Li X; Hanna MG; Blenman KRM; Salgado R; Gallas BD
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.
    Wein L; Savas P; Luen SJ; Virassamy B; Salgado R; Loi S
    Front Oncol; 2017; 7():156. PubMed ID: 28824872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    Gao G; Wang Z; Qu X; Zhang Z
    BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
    Amgad M; Stovgaard ES; Balslev E; Thagaard J; Chen W; Dudgeon S; Sharma A; Kerner JK; Denkert C; Yuan Y; AbdulJabbar K; Wienert S; Savas P; Voorwerk L; Beck AH; Madabhushi A; Hartman J; Sebastian MM; Horlings HM; Hudeček J; Ciompi F; Moore DA; Singh R; Roblin E; Balancin ML; Mathieu MC; Lennerz JK; Kirtani P; Chen IC; Braybrooke JP; Pruneri G; Demaria S; Adams S; Schnitt SJ; Lakhani SR; Rojo F; Comerma L; Badve SS; Khojasteh M; Symmans WF; Sotiriou C; Gonzalez-Ericsson P; Pogue-Geile KL; Kim RS; Rimm DL; Viale G; Hewitt SM; Bartlett JMS; Penault-Llorca F; Goel S; Lien HC; Loibl S; Kos Z; Loi S; Hanna MG; Michiels S; Kok M; Nielsen TO; Lazar AJ; Bago-Horvath Z; Kooreman LFS; van der Laak JAWM; Saltz J; Gallas BD; Kurkure U; Barnes M; Salgado R; Cooper LAD;
    NPJ Breast Cancer; 2020; 6():16. PubMed ID: 32411818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes.
    Deman F; Punie K; Laenen A; Neven P; Oldenburger E; Smeets A; Nevelsteen I; Van Ongeval C; Baten A; Faes T; Christiaens M; Janssen H; Weltens C; Desmedt C; Wildiers H; Floris G
    Breast Cancer Res Treat; 2020 Dec; 184(3):985-998. PubMed ID: 32920743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma.
    Yap FW; Rasotto R; Priestnall SL; Parsons KJ; Stewart J
    Vet Comp Oncol; 2017 Dec; 15(4):1553-1557. PubMed ID: 28133880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.
    Ochi T; Bianchini G; Ando M; Nozaki F; Kobayashi D; Criscitiello C; Curigliano G; Iwamoto T; Niikura N; Takei H; Yoshida A; Takei J; Suzuki K; Yamauchi H; Hayashi N
    Eur J Cancer; 2019 Sep; 118():41-48. PubMed ID: 31302586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting.
    Carbognin L; Pilotto S; Nortilli R; Brunelli M; Nottegar A; Sperduti I; Giannarelli D; Bria E; Tortora G
    Oncologist; 2016 Mar; 21(3):283-91. PubMed ID: 26865589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
    Beckers RK; Selinger CI; Vilain R; Madore J; Wilmott JS; Harvey K; Holliday A; Cooper CL; Robbins E; Gillett D; Kennedy CW; Gluch L; Carmalt H; Mak C; Warrier S; Gee HE; Chan C; McLean A; Walker E; McNeil CM; Beith JM; Swarbrick A; Scolyer RA; O'Toole SA
    Histopathology; 2016 Jul; 69(1):25-34. PubMed ID: 26588661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the Tumor-Stroma Ratio and Tumor-Infiltrating Lymphocytes in Colorectal Cancer: Inter-Observer Agreement Evaluation.
    Kazemi A; Gharib M; Mohamadian Roshan N; Taraz Jamshidi S; Stögbauer F; Eslami S; Schüffler PJ
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS)--inter-observer and intra-observer reproducibility of a compartment-based scoring system.
    Kornaat PR; Ceulemans RY; Kroon HM; Riyazi N; Kloppenburg M; Carter WO; Woodworth TG; Bloem JL
    Skeletal Radiol; 2005 Feb; 34(2):95-102. PubMed ID: 15480649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated Detection and Scoring of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology Slides.
    Yosofvand M; Khan SY; Dhakal R; Nejat A; Moustaid-Moussa N; Rahman RL; Moussa H
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers.
    Thagaard J; Stovgaard ES; Vognsen LG; Hauberg S; Dahl A; Ebstrup T; Doré J; Vincentz RE; Jepsen RK; Roslind A; Kümler I; Nielsen D; Balslev E
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
    Skriver SK; Jensen MB; Knoop AS; Ejlertsen B; Laenkholm AV
    Breast Cancer Res; 2020 May; 22(1):46. PubMed ID: 32410705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.
    Pruneri G; Vingiani A; Bagnardi V; Rotmensz N; De Rose A; Palazzo A; Colleoni AM; Goldhirsch A; Viale G
    Ann Oncol; 2016 Feb; 27(2):249-56. PubMed ID: 26598540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.
    Dieci MV; Mathieu MC; Guarneri V; Conte P; Delaloge S; Andre F; Goubar A
    Ann Oncol; 2015 Aug; 26(8):1698-704. PubMed ID: 25995301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.